A multidisciplinary clinic in Umm Suqeim 1 with first-party pages for semaglutide and other prescription weight-management medicines.
Availability does not establish approval or effectiveness. Ask for the exact active ingredient, product registration, indication, prescriber, dispensing source, risks, alternatives, and follow-up plan.
The clinic documents prescription Ozempic, Mounjaro, Wegovy, and Saxenda pathways. Approval is product- and indication-specific: a registered medicine used off-label is not automatically approved for the promoted purpose.
EuroMed's official articles state different indicative price ranges for the same GLP-1 medicines.
No single clinic price can be displayed reliably. Confirm the exact registered product, strength, dispensing source and total care cost directly.
Price information is attributed to the clinic and may change. It does not establish medical approval, product registration, effectiveness or the total cost of care.
These labels assess the named molecule, not the clinic’s particular product, protocol or marketing claim. UAE registration remains product and indication specific.
| Peptide | Category | Evidence | Approval note | Editorial assessment |
|---|---|---|---|---|
| Liraglutide | Prescription medicine | High | Product and indication specific | An established prescription medicine for specific indications. Confirm the exact product, prescriber and UAE registration. |
| Semaglutide | Prescription medicine | High | Product and indication specific | Supported by substantial human evidence for specific approved metabolic indications. Verify the exact UAE-registered brand and intended use. |
| Tirzepatide | Prescription medicine | High | Product and indication specific | Supported by substantial human evidence for specific approved metabolic indications. Registration does not cover every promoted use. |
Confirm current hours with the clinic
+971 4 894 5000Compare clinical assessment, product traceability, informed consent, monitoring, adverse-event support, and alternatives—not marketing claims.
Is this information outdated? Send the editorial team a correction.Clinics cannot pay to change directory order or evidence classifications.